APEN logo

Apollo Endosurgery (APEN) Cash From Investing

Annual CFI

-$2.75 M
-$4.31 M-275.85%

December 31, 2022

Summary

Performance

1-Year Change

-275.85%

3-Year Change

-364.45%

5-Year Change

-28.45%

15-Year Change

-28.45%

APEN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$7.12 M
APEN annual cash flow from investing activities is currently -138.56% below its historical high of $7.12 million

3-Year Low

-$2.75 M
APEN annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
APEN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
APEN next annual earnings announcement has not yet been scheduled

OtherAPENcash flowmetrics:

Annual CFF

$349.00 K
APEN annual cash flow from financing activities is $349.00 thousand

Annual CFO

-$31.26 M
APEN annual cash flow from operations is -$31.26 million

Annual FCF

-$34.01 M
APEN annual free cash flow is -$34.01 million

Annual CAPEX

$2.75 M
APEN annual capital expenditures is $2.75 million

Quarterly CFI

-$512.00 K
+$614.00 K+54.53%

December 31, 2022

Summary

Performance

3-Month Change

+54.53%

1-Year Change

-120.3%

3-Year Change

-130.71%

5-Year Change

-11.3%

APEN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.84 M
APEN quarterly cash flow from investing activities is currently -105.20% below its historical high of $9.84 million

3-Year Low

-$1.13 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
APEN previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
APEN next earnings announcement has not yet been scheduled

OtherAPENcash flowmetrics:

Quarterly CFF

$371.00 K
APEN quarterly cash flow from financing activities is $371.00 thousand

Quarterly CFO

-$10.30 M
APEN quarterly cash flow from operations is -$10.30 million

Quarterly FCF

-$10.81 M
APEN quarterly free cash flow is -$10.81 million

Quarterly CAPEX

$512.00 K
APEN quarterly capital expenditures is $512.00 thousand

TTM CFI

-$2.75 M
-$3.03 M-1049.83%

December 31, 2022

Summary

Performance

3-Month Change

-1049.83%

1-Year Change

-275.85%

3-Year Change

-364.45%

5-Year Change

-364.45%

APEN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.21 M
APEN TTM cash flow from investing activities is currently -129.81% below its historical high of $9.21 million

3-Year Low

-$2.75 M
APEN TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
APEN previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
APEN next earnings announcement has not yet been scheduled

OtherAPENcash flowmetrics:

TTM CFF

$349.00 K
APEN TTM cash flow from financing activities is $349.00 thousand

TTM CFO

-$31.26 M
APEN TTM cash flow from operations is -$31.26 million

TTM FCF

-$34.01 M
APEN TTM free cash flow is -$34.01 million

TTM CAPEX

$2.75 M
APEN TTM capital expenditures is $2.75 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

APEN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-275.9%-120.3%-275.9%
3 y3 years-364.4%-130.7%-364.4%
5 y5 years-28.4%-11.3%-364.4%

APEN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-275.8%at low-120.3%+119.9%-275.8%at low
5 y5-year-275.8%at low-120.3%+119.9%-275.8%at low
alltimeall time-138.6%at low-105.2%+280.7%-129.8%+32.1%

Apollo Endosurgery Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2022
-$2.75 M(-275.8%)
-$512.00 K(-54.5%)
-$2.75 M(-1049.8%)
Sep 2022
-
-$1.13 M(+102.5%)
$289.00 K(-74.5%)
Jun 2022
-
-$556.00 K(+0.9%)
$1.13 M(-13.4%)
Mar 2022
-
-$551.00 K(-121.8%)
$1.31 M(-16.3%)
Dec 2021
$1.56 M(+13.9%)
$2.52 M(-991.2%)
$1.56 M(+63.1%)
Sep 2021
-
-$283.00 K(-25.7%)
$957.00 K(-16.8%)
Jun 2021
-
-$381.00 K(+28.3%)
$1.15 M(-17.3%)
Mar 2021
-
-$297.00 K(-115.5%)
$1.39 M(+1.5%)
Dec 2020
$1.37 M(+32.0%)
$1.92 M(-2231.1%)
$1.37 M(+22.4%)
Sep 2020
-
-$90.00 K(-35.7%)
$1.12 M(+7.8%)
Jun 2020
-
-$140.00 K(-56.0%)
$1.04 M(+15.7%)
Mar 2020
-
-$318.00 K(-119.1%)
$897.00 K(-13.6%)
Dec 2019
$1.04 M(-85.4%)
$1.67 M(-1074.9%)
$1.04 M(-88.7%)
Sep 2019
-
-$171.00 K(-39.1%)
$9.21 M(+7.6%)
Jun 2019
-
-$281.00 K(+58.8%)
$8.56 M(+3.9%)
Mar 2019
-
-$177.00 K(-101.8%)
$8.23 M(+15.7%)
Dec 2018
$7.12 M(-433.1%)
$9.84 M(-1295.4%)
$7.12 M(-323.9%)
Sep 2018
-
-$823.00 K(+36.5%)
-$3.18 M(+19.6%)
Jun 2018
-
-$603.00 K(-53.4%)
-$2.66 M(-11.4%)
Mar 2018
-
-$1.29 M(+181.1%)
-$3.00 M(+40.4%)
Dec 2017
-$2.14 M(-1.3%)
-$460.00 K(+52.3%)
-$2.14 M(-41.1%)
Sep 2017
-
-$302.00 K(-68.0%)
-$3.63 M(+5.3%)
Jun 2017
-
-$945.00 K(+119.8%)
-$3.44 M(+35.6%)
Mar 2017
-
-$430.00 K(-77.9%)
-$2.54 M(+17.3%)
Dec 2016
-$2.17 M(+643.5%)
-$1.95 M(+1522.8%)
-$2.16 M(+674.3%)
Sep 2016
-
-$120.10 K(+192.2%)
-$279.60 K(+27.5%)
Jun 2016
-
-$41.10 K(-24.9%)
-$219.30 K(-10.8%)
Mar 2016
-
-$54.70 K(-14.1%)
-$245.90 K(-15.6%)
Dec 2015
-$291.20 K(-45.7%)
-$63.70 K(+6.5%)
-$291.20 K(-18.1%)
Sep 2015
-
-$59.80 K(-11.7%)
-$355.50 K(-12.8%)
Jun 2015
-
-$67.70 K(-32.3%)
-$407.80 K(-8.6%)
Mar 2015
-
-$100.00 K(-21.9%)
-$446.20 K(-16.8%)
Dec 2014
-$535.90 K(+37.0%)
-$128.00 K(+14.2%)
-$536.00 K(+9.6%)
Sep 2014
-
-$112.10 K(+5.7%)
-$489.10 K(+5.5%)
Jun 2014
-
-$106.10 K(-44.1%)
-$463.60 K(-6.5%)
Mar 2014
-
-$189.80 K(+134.0%)
-$495.80 K(+26.8%)
DateAnnualQuarterlyTTM
Dec 2013
-$391.10 K(+13.6%)
-$81.10 K(-6.4%)
-$391.00 K(+11.8%)
Sep 2013
-
-$86.60 K(-37.4%)
-$349.60 K(-5.1%)
Jun 2013
-
-$138.30 K(+62.7%)
-$368.20 K(+1.4%)
Mar 2013
-
-$85.00 K(+114.1%)
-$363.10 K(+5.5%)
Dec 2012
-$344.30 K(-29.6%)
-$39.70 K(-62.3%)
-$344.30 K(-10.8%)
Sep 2012
-
-$105.20 K(-21.0%)
-$386.10 K(-24.8%)
Jun 2012
-
-$133.20 K(+101.2%)
-$513.20 K(+1.2%)
Mar 2012
-
-$66.20 K(-18.8%)
-$507.00 K(+3.7%)
Dec 2011
-$489.00 K(+4.4%)
-$81.50 K(-64.9%)
-$489.10 K(-2.3%)
Sep 2011
-
-$232.30 K(+82.9%)
-$500.40 K(+47.8%)
Jun 2011
-
-$127.00 K(+162.9%)
-$338.50 K(-8.1%)
Mar 2011
-
-$48.30 K(-48.0%)
-$368.30 K(-21.4%)
Dec 2010
-$468.50 K(-17.8%)
-$92.80 K(+31.8%)
-$468.50 K(-0.1%)
Sep 2010
-
-$70.40 K(-55.1%)
-$468.90 K(-20.3%)
Jun 2010
-
-$156.80 K(+5.6%)
-$588.50 K(+0.8%)
Mar 2010
-
-$148.50 K(+59.3%)
-$584.10 K(+2.5%)
Dec 2009
-$569.90 K(+377.3%)
-$93.20 K(-50.9%)
-$569.80 K(+7.1%)
Sep 2009
-
-$190.00 K(+24.7%)
-$532.20 K(+53.9%)
Jun 2009
-
-$152.40 K(+13.6%)
-$345.70 K(+45.4%)
Mar 2009
-
-$134.20 K(+141.4%)
-$237.70 K(+99.1%)
Dec 2008
-$119.40 K(-56.8%)
-$55.60 K(+1488.6%)
-$119.40 K(-20.5%)
Sep 2008
-
-$3500.00(-92.1%)
-$150.10 K(-35.0%)
Jun 2008
-
-$44.40 K(+179.2%)
-$230.80 K(-14.7%)
Mar 2008
-
-$15.90 K(-81.6%)
-$270.70 K(-2.1%)
Dec 2007
-$276.50 K(-5.7%)
-$86.30 K(+2.5%)
-$276.40 K(+20.6%)
Sep 2007
-
-$84.20 K(-0.1%)
-$229.20 K(-28.9%)
Jun 2007
-
-$84.30 K(+290.3%)
-$322.30 K(+15.4%)
Mar 2007
-
-$21.60 K(-44.8%)
-$279.20 K(-4.7%)
Dec 2006
-$293.10 K(+99.1%)
-$39.10 K(-77.9%)
-$293.10 K(-6.1%)
Sep 2006
-
-$177.30 K(+330.3%)
-$312.00 K(+92.2%)
Jun 2006
-
-$41.20 K(+16.1%)
-$162.30 K(+4.2%)
Mar 2006
-
-$35.50 K(-38.8%)
-$155.80 K(+5.8%)
Dec 2005
-$147.20 K
-$58.00 K(+110.1%)
-$147.20 K(+65.0%)
Sep 2005
-
-$27.60 K(-20.5%)
-$89.20 K(+44.8%)
Jun 2005
-
-$34.70 K(+29.0%)
-$61.60 K(+129.0%)
Mar 2005
-
-$26.90 K
-$26.90 K

FAQ

  • What is Apollo Endosurgery annual cash flow from investing activities?
  • What is the all time high annual CFI for Apollo Endosurgery?
  • What is Apollo Endosurgery annual CFI year-on-year change?
  • What is Apollo Endosurgery quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Apollo Endosurgery?
  • What is Apollo Endosurgery quarterly CFI year-on-year change?
  • What is Apollo Endosurgery TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Apollo Endosurgery?
  • What is Apollo Endosurgery TTM CFI year-on-year change?

What is Apollo Endosurgery annual cash flow from investing activities?

The current annual CFI of APEN is -$2.75 M

What is the all time high annual CFI for Apollo Endosurgery?

Apollo Endosurgery all-time high annual cash flow from investing activities is $7.12 M

What is Apollo Endosurgery annual CFI year-on-year change?

Over the past year, APEN annual cash flow from investing activities has changed by -$4.31 M (-275.85%)

What is Apollo Endosurgery quarterly cash flow from investing activities?

The current quarterly CFI of APEN is -$512.00 K

What is the all time high quarterly CFI for Apollo Endosurgery?

Apollo Endosurgery all-time high quarterly cash flow from investing activities is $9.84 M

What is Apollo Endosurgery quarterly CFI year-on-year change?

Over the past year, APEN quarterly cash flow from investing activities has changed by -$3.03 M (-120.30%)

What is Apollo Endosurgery TTM cash flow from investing activities?

The current TTM CFI of APEN is -$2.75 M

What is the all time high TTM CFI for Apollo Endosurgery?

Apollo Endosurgery all-time high TTM cash flow from investing activities is $9.21 M

What is Apollo Endosurgery TTM CFI year-on-year change?

Over the past year, APEN TTM cash flow from investing activities has changed by -$4.31 M (-275.85%)